Diroximel fumarate

Name: Diroximel fumarate
Availability: diroximel-fumarate-357373.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Diroximel fumarate
CAS No.:1577222-14-0
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

2-Chloro-6-(trifluoromethyl)quinoxaline

Vitamin AD3

Zidovudine*Lamivudine co packed with Nevirapine

Anagrelide

Prosaconazole

(1S.3R,4R)-3-( Boc-aMino)-4- hydroxy- cyclohexanecarboxylic acid ethyl ester

5-Me-DMT-dC(Bz)-CE Phosphoramidite

thymopentin

5-bromo-isophthalic acid dimethyl ester

Sitagliptin Phosphate + Metformin

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Multiple Sclerosis (MS) is a chronic, debilitating neurological disease that can lead to profound cognitive and physical symptoms, severely affecting quality of life. It is the main cause of neurological disability not caused by trauma in the young adult population of both North America and Europe. Relapsing-remitting forms of MS lead to neurological symptoms that resolve and recur periodically. Diroximel fumarate was formulated by Alkermes in collaboration with Biogen, and was approved by the FDA in October 2019 and by the EMA in November 2021.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification: